Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Valero Energy Corporation (VLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Valero Energy Corporation — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.97 (market cap $31.07B), while Valero Energy Corporation trades at $461.04 (market cap $131.43B). The key difference: Valero Energy Corporation is far larger — about 4.2× GE HealthCare Technologies Inc. Common Stock's market cap, and Valero Energy Corporation pays the higher dividend (1.05%). Which is the better fit depends on your goals.
| GEHC | VLO | |
|---|---|---|
Market Cap | $31.07B | $131.43B |
Volume | 3,443,020 | 2,513,030 |
Sector | Health | Energy |
52-Week High | $88.16 | $459.78 |
52-Week Low | $59.48 | $156.39 |
Enterprise Value | $39.53B | $134.90B |
Dividend Yield | 0.23% | 1.05% |
Typical Hold Time | — | 57 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Valero Energy (VLO) trades at $456.46, up 4.69% today and near its 52-week high, with a bullish technical outlook supported by moving averages. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 expected at $20.83 EPS. Revenue declined to $122.69B in 2025, but net income margin improved to 5.17%, and strong cash flow supports a $1.20 dividend. Analyst sentiment is positive with 57% buy ratings.
VLO presents a bullish case with robust profitability and growth prospects, but faces risks from volatile refining margins and potential policy impacts like diesel export bans. The stock's valuation at a P/E of 19.04 is reasonable given high ROE of 29.31%, though high RSI levels suggest caution for near-term entry.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Valero Energy Corporation
Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →
